Skip to main content

Table 4 Relationship between ePWV and 30-day mortality in different subgroups

From: Association between estimated pulse wave velocity and the risk of mortality in patients with subarachnoid hemorrhage: a retrospective cohort study based on the MIMIC database

ePWV levels

HR (95% CI)

P

HR (95% CI)

P

 

< 65 years old

≥ 65 years old

< 10.12

Ref

 

Ref

 

[10.12–12.10)

2.42 (1.49–3.93)

< 0.001

1.03 (0.57–1.85)

0.925

≥ 12.10

2.28 (0.81–6.40)

0.118

2.39 (1.40–4.10)

0.001

 

SOFA < 2

SOFA ≥ 2

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.00 (0.57–1.75)

1.000

1.13 (0.70–1.82)

0.609

≥ 12.10

2.22 (1.19–4.17)

0.013

1.24 (0.71–2.18)

0.447

 

Non-surgery

Surgery

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.23 (0.85–1.77)

0.271

0.54 (0.07–3.91)

0.541

≥ 12.10

1.84 (1.21–2.78)

0.004

2.24 (0.19–26.75)

0.525

 

Non-AF

AF

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.19 (0.82–1.72)

0.360

2.12 (0.35–12.71)

0.412

≥ 12.10

1.75 (1.14–2.69)

0.011

3.23 (0.37–27.90)

0.287

 

Non-RF

RF

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.14 (0.76–1.72)

0.519

2.43 (1.02–5.80)

0.045

≥ 12.10

2.16 (1.34–3.50)

0.002

0.84 (0.28–2.48)

0.754

 

Non-hepatic diseases

Hepatic diseases

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.21 (0.83–1.76)

0.324

1.18 (0.28–5.03)

0.824

≥ 12.10

1.93 (1.25–2.99)

0.003

0.38 (0.06–2.33)

0.296

 

Non-COPD

COPD

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.47 (1.05–2.06)

0.024

0.56 (0.20–1.52)

0.255

≥ 12.10

2.29 (1.55–3.38)

< 0.001

0.52 (0.14–1.92)

0.328

 

Non-sepsis

Sepsis

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.08 (0.63–1.87)

0.779

1.15 (0.69–1.90)

0.594

≥ 12.10

1.89 (0.98–3.65)

0.058

1.78 (1.02–3.11)

0.043

 

Non-hypertension

Hypertension

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.04 (0.58–1.87)

0.893

1.30 (0.81–2.10)

0.278

≥ 12.10

2.52 (1.31–4.84)

0.005

1.61 (0.91–2.85)

0.103

 

Non-DM

DM

< 10.12

Ref

 

Ref

 

[10.12–12.10)

1.15 (0.78–1.68)

0.482

1.68 (0.54–5.22)

0.370

≥ 12.10

2.02 (1.30–3.15)

0.002

1.71 (0.47–6.32)

0.418

  1. ePWV: estimated pulse wave velocity, SAH: subarachnoid hemorrhage, HR: hazard ratio, CI: confidence interval, Ref: reference
  2. Age subgroups adjusted for: ICU types, HF, AF, RF, hepatic diseases, sepsis, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  3. SOFA subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, sepsis, DM, malignancy, HR, RR, temperature, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  4. Surgery subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, sepsis, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  5. AF subgroups adjusted for: age, ICU types, HF, RF, hepatic diseases, sepsis, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  6. RF subgroups adjusted for: age, ICU types, HF, AF, hepatic diseases, sepsis, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  7. Hepatic diseases subgroups adjusted for: age, ICU types, HF, AF, RF, sepsis, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  8. COPD subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, sepsis, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  9. Sepsis subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  10. Hypertension subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, sepsis, DM, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT;
  11. DM subgroups adjusted for: age, ICU types, HF, AF, RF, hepatic diseases, sepsis, malignancy, HR, RR, temperature, SOFA, WBC, Cr, Ca, mechanical ventilation use, vasopressor use, and RRT